Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
The aforementioned studies indicate that a ferroptosis inducer may serve as a promising pharmaceutical agent for the treatment of GC
Am J Physiol Cell Physiol 281(4):C1077-1093
Oxyde (GSSG)
Lyophilised AOD-9604 powder must be reconstituted with bacteriostatic water at concentrations typically between 2mg/mL and 5mg/mLresearchers often prepare a 2mg vial with 1mL of diluent to yield a 2mg/mL solution, where a 0.25mL (250mcg) injection delivers the lower end of the therapeutic range
The product must provide safety and efficacy evidence and meet FDA requirements for drug approval
Decades of research and clinical use confirm minimal risk when used appropriately
US$ 27.90
US$ 22.21
US$ 28.70
US$ 21.73
